BioAge Labs Posts $0.73 Q3 GAAP Loss Per Share as Revenue Drops 85.7%

Revenue was $0.3 million, missing estimates by $1.18 million. Cash, cash equivalents and marketable securities totaled about $352.3 million at Sept. 30.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.